Harvard Management Company’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-341,972
| Closed | -$1.13M | – | 24 |
|
|
2023
Q2 | $1.13M | Sell |
341,972
-68,742
| -17% | -$227K | 0.11% | 25 |
|
|
2023
Q1 | $1.17M | Hold |
410,714
| – | – | 0.12% | 40 |
|
|
2022
Q4 | $2.99M | Hold |
410,714
| – | – | 0.37% | 29 |
|
|
2022
Q3 | $3.32M | Hold |
410,714
| – | – | 0.41% | 27 |
|
|
2022
Q2 | $2.01M | Hold |
410,714
| – | – | 0.23% | 34 |
|
|
2022
Q1 | $9.71M | Hold |
410,714
| – | – | 0.98% | 13 |
|
|
2021
Q4 | $7.27M | Hold |
410,714
| – | – | 0.68% | 32 |
|
|
2021
Q3 | $11.6M | Hold |
410,714
| – | – | 0.68% | 21 |
|
|
2021
Q2 | $4.3M | Hold |
410,714
| – | – | 0.25% | 27 |
|
|
2021
Q1 | $4.84M | Hold |
410,714
| – | – | 0.27% | 29 |
|
|
2020
Q4 | $4.81M | Hold |
410,714
| – | – | 0.26% | 20 |
|
|
2020
Q3 | $3.26M | Hold |
410,714
| – | – | 0.18% | 21 |
|
|
2020
Q2 | $7.51M | Hold |
410,714
| – | – | 0.64% | 14 |
|
|
2020
Q1 | $4.9M | Hold |
410,714
| – | – | 0.77% | 12 |
|
|
2019
Q4 | $6.83M | Hold |
410,714
| – | – | 0.72% | 12 |
|
|
2019
Q3 | $2.73M | Buy |
+410,714
| New | +$2.73M | 0.25% | 15 |
|